Biomerk Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Ambala, Haryana, India, established in 2022.
2022 Ambala, Haryana, India Active
Last Updated:
Access Report
About Biomerk Pharmaceuticals Private Limited

Biomerk Pharmaceuticals Private Limited, a active private limited company, was established on 17 March 2022 in Ambala, Haryana, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24290HR2022PTC102103. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Preeti (Director), Gaurav Jain (Director). Past directors included Rakesh Kumar. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at H.No 28 Jaggi Colony Ambala City, Ambala, Haryana, 134203.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290HR2022PTC102103

  • Registration Number

    102103

  • Incorporation Date

    17 March 2022

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 3 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Biomerk Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Biomerk Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Biomerk Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Preeti Director 17 Mar 2022 Current
Gaurav Jain Director 17 Mar 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 31 May 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Biomerk Pharmaceuticals.

Enhance accessibility to Biomerk Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Biomerk Pharmaceuticals revenue growth over time
Biomerk Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Biomerk Pharmaceuticals?

Unlock access to Biomerk Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Biomerk Pharmaceuticals?

Biomerk Pharmaceuticals has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Biomerk Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biomerk Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Biomerk Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Biomerk Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Biomerk Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    Preeti was appointed as a Director was appointed as a Director on 17 Mar 2022 & has been associated with this company since 3 years 11 months . was recorded as a recent event.

  • Director Appointment

    The activity Gaurav Jain was appointed as a Director was appointed as a Director on 17 Mar 2022 & has been associated with this company since 3 years 11 months . was completed.

  • Company Incorporation

    The activity Biomerk Pharmaceuticals Private Limited was registered on 17 Mar 2022 with Roc Delhi & aged 3 years 11 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Biomerk Pharmaceuticals Private Limited?

The CIN of Biomerk Pharmaceuticals Private Limited is U24290HR2022PTC102103.

Where is Biomerk Pharmaceuticals Private Limited headquartered?

Biomerk Pharmaceuticals Private Limited is headquartered at H.No 28 Jaggi Colony Ambala City, Ambala, Haryana, 134203.

When was Biomerk Pharmaceuticals Private Limited incorporated?

Biomerk Pharmaceuticals Private Limited was incorporated on 17 March 2022.

Who are the current directors of Biomerk Pharmaceuticals Private Limited?

The current directors of Biomerk Pharmaceuticals Private Limited are

What is the primary industry of Biomerk Pharmaceuticals Private Limited?

The primary industry of Biomerk Pharmaceuticals Private Limited is Chemicals.

Is Biomerk Pharmaceuticals Private Limited a listed company?

Biomerk Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Biomerk Pharmaceuticals Private Limited?

The authorized capital of Biomerk Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available